Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
Clinical Endocrinology
|
June 4, 2016
Proopiomelanocortin interference in the measurement of adrenocorticotrophic hormone: a United Kingdom National External Quality Assessment Service study
P J Monaghan, A Kyriacou, C Sturgeon, et al.
American Journal of Obstetrics and Gynecology
|
June 3, 1998
Pregnant women with impaired tolerance to an oral glucose load in the afternoon: evidence suggesting that they behave metabolically as patients with gestational diabetes
N J Aparicio, M A Joao, M Cortelezzi, et al.
Blood
|
May 9, 2001
The relative quiescence of hematopoietic stem cells in nonhuman primates
N Mahmud, S M Devine, K P Weller, et al.
The International Journal of Biological Markers
|
July 29, 1998
The prognostic significance of increasing marker levels in metastatic breast cancer patients with clinically complete remission, partial remission or stable disease
A Van Dalen, V Barak, A Cremaschi, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
March 15, 2002
The ISOBM TD-7 Workshop on hCG and related molecules. Towards user-oriented standardization of pregnancy and tumor diagnosis: assignment of epitopes to the three-dimensional structure of diagnostically and commercially relevant monoclonal antibodies directed against human chorionic gonadotropin and derivatives
P Berger, C Sturgeon, J M Bidart, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 26, 2003
Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines
M J Duffy, A van Dalen, C Haglund, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 20, 2009
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report
M J Duffy, C Sturgeon, R Lamerz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 22, 2007
Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use
M J Duffy, A van Dalen, C Haglund, et al.
Annals of Clinical Biochemistry
|
June 8, 2001
Pre- and post-analytical factors that may influence use of serum prostate specific antigen and its isoforms in a screening programme for prostate cancer
C P Price, J Allard, G Davies, et al.
Digestive Diseases and Sciences
|
May 5, 2016
Clinical Activity and Quality of Life Indices Are Valid Across Ulcerative Colitis But Not Crohn's Disease Phenotypes
Sasha Taleban, Kathleen O Stewart, Darrick K Li, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
Clinical Endocrinology
|
June 4, 2016
Proopiomelanocortin interference in the measurement of adrenocorticotrophic hormone: a United Kingdom National External Quality Assessment Service study
P J Monaghan, A Kyriacou, C Sturgeon, et al.
American Journal of Obstetrics and Gynecology
|
June 3, 1998
Pregnant women with impaired tolerance to an oral glucose load in the afternoon: evidence suggesting that they behave metabolically as patients with gestational diabetes
N J Aparicio, M A Joao, M Cortelezzi, et al.
Blood
|
May 9, 2001
The relative quiescence of hematopoietic stem cells in nonhuman primates
N Mahmud, S M Devine, K P Weller, et al.
The International Journal of Biological Markers
|
July 29, 1998
The prognostic significance of increasing marker levels in metastatic breast cancer patients with clinically complete remission, partial remission or stable disease
A Van Dalen, V Barak, A Cremaschi, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
March 15, 2002
The ISOBM TD-7 Workshop on hCG and related molecules. Towards user-oriented standardization of pregnancy and tumor diagnosis: assignment of epitopes to the three-dimensional structure of diagnostically and commercially relevant monoclonal antibodies directed against human chorionic gonadotropin and derivatives
P Berger, C Sturgeon, J M Bidart, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 26, 2003
Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines
M J Duffy, A van Dalen, C Haglund, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 20, 2009
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report
M J Duffy, C Sturgeon, R Lamerz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 22, 2007
Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use
M J Duffy, A van Dalen, C Haglund, et al.
Annals of Clinical Biochemistry
|
June 8, 2001
Pre- and post-analytical factors that may influence use of serum prostate specific antigen and its isoforms in a screening programme for prostate cancer
C P Price, J Allard, G Davies, et al.
Digestive Diseases and Sciences
|
May 5, 2016
Clinical Activity and Quality of Life Indices Are Valid Across Ulcerative Colitis But Not Crohn's Disease Phenotypes
Sasha Taleban, Kathleen O Stewart, Darrick K Li, et al.
Page
of 5